Reviva Pharmaceuticals -CW23RVPHWPreferred / convertible
13F holders, Q2 2025 (June 30)3holders +2
3new positions
1sold out
$0.03avg. 13F price*
At the end of Q2 2025, 3 institutions reported holding Reviva Pharmaceuticals -CW23 (RVPHW) in their 13F filings, up 2 from Q1 2025. 3 opened new positions and 1 sold out. The largest holders were Susquehanna International Group, LLP ($489), Toronto Dominion Bank ($3) and Clear Street LLC ($1).
- Company
- Reviva Pharmaceuticals -CW23
- CUSIP
- 76152G118
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $493 |
| Exits | 1 | $1K |
All 13F filers, Q1 2025 → Q2 2025: 15,323 shares bought and 16,100 shares sold, net −777 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Susquehanna International Group, LLP | — | New | 15,201 | $489 |
| Toronto Dominion Bank | — | New | 100 | $3 |
| Clear Street LLC | — | New | 22 | $1 |
"% of holder's portfolio" is RVPHW's weight in each manager's 13F, not the share of Reviva Pharmaceuticals -CW23 the manager owns.